The invention is directed to novel isonipecotamide derivatives of Formula (I): ##STR00001## which are useful in treating integrin-mediated disorders.

 
Web www.patentalert.com

< Heteroarylacetamide inhibitors of factor Xa

< Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase

> Di-substituted oxadiazoles as CXC-chemokine receptor ligands

> Heteroaryl carboxamides
~ 00608